Edited by:
Rajesh Singh, PhD, Morehouse School of Medicine, United States of America
Journal of Ovarian Research is calling for submissions to our Collection on Nanotechnological Approaches for the Treatment of Ovarian Cancer.
Image credit: © catalin / stock.adobe.com
This collection supports and amplifies research related to SDG 3: [Good health and well-being]
Journal of Ovarian Research is calling for submissions to our Collection on Nanotechnological Approaches for the Treatment of Ovarian Cancer. For women, gynecological cancer is the most destructive malignancy. Current treatment options include surgery, chemotherapy, hormonal, and radiation therapy; however, there is no effective treatment for advanced-stage, refractory, recurrent, and drug-resistant cases. Drug-delivering nanocarriers can be used to deliver novel therapeutic agents to treat certain gynecological cancers, such as cervical, ovarian, uterine, vaginal, and vulvar. However, the precise cause of this fatal cancer remains unknown. So, understanding the essential components of this diverse group of cancers is necessary. As a result, researchers are looking for strategies to overcome this deadly disease. Targeted therapies have begun to receive recognition as cutting-edge and extremely promising therapeutic approaches. These treatments have the potential to be innovative and effective ways to enhance patients' quality of life, and they could offer hope to medical professionals searching for fresh treatment targets.
For this collection, we welcome you to submit the original research, review articles, and commentaries on the latest progress on the novel and targeted nano-therapy and its underlying mechanism, including the diagnosis and symptoms of ovarian cancer.
There are currently no articles in this collection.
This Collection welcomes submission of original research, review articles, and commentaries. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Nanotechnological Approaches for the Treatment of Ovarian Cancer" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.